
OLD Category: signatures
September 6, 2021 / Arch Med Res
Seroconversion in septic ICU patients presenting with COVID-19: necessary but not sufficient
September 6, 2021 / Curr Oncol
New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas
September 4, 2021 / Biomolecules
Shifting Gears in Precision Oncology—Challenges and Opportunities of Integrative Data Analysis
September 3, 2021 / ESMO Open
Refining patient selection for breast cancer immunotherapy: beyond PD-L1
September 3, 2021 / ESMO Open
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
September 3, 2021 / Cancer Discov
Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
September 3, 2021 / Blood Adv
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype
September 2, 2021 / J Cancer Res Clin Oncol
The association of immunosurveillance and distant metastases in colorectal cancer
September 1, 2021 / Gland Surg
Advancement of prognostic models in breast cancer: a narrative review
September 1, 2021 / J Clin Invest